PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung disease |
| Phenotype | C0003873|rheumatoid arthritis |
| Sentences | 36 |
| PubMedID- 26508946 | However, these agents are widely prescribed for patients with ankylosing spondylitis, and case reports describe beneficial effects in patients with interstitial lung disease associated with rheumatoid arthritis. |
| PubMedID- 22341526 | Objective: to describe the evolution of lung function in a cohort of rheumatoid arthritis (ra) patients with interstitial lung disease (ild) treated according to the medical judgment of attending physicians. |
| PubMedID- 24378059 | Objective: to investigate the effect of selective phosphodiesterase (pde) 4 inhibitors on nuclear factor kappa b (nf-kappab), tumor necrosis factor-alpha (tnfalpha) and interleukin-8 (il-8) secreted by peripheral blood mononuclear cells (pbmcs) in patients diagnosed as rheumatoid arthritis with interstitial lung disease (ra-ild). |
| PubMedID- 24743261 | Anti-cyclic citrullinated peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis. |
| PubMedID- 25746669 | A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in chinese patients. |
| PubMedID- 25922727 | Changes in peripheral cd19(+)foxp3(+) and cd19(+)tgfbeta(+) regulatory b cell populations in rheumatoid arthritis patients with interstitial lung disease. |
| PubMedID- 25125479 | Potential risk of tnf inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis. |
| PubMedID- 23661426 | A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis. |
| PubMedID- 23899235 | Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis. |
| PubMedID- 24570384 | Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced. |
| PubMedID- 24521636 | Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: a pilot study. |
| PubMedID- 24757133 | Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. |
| PubMedID- 26401101 | Management of rheumatoid arthritis patients with interstitial lung disease: safety of biological antirheumatic drugs and assessment of pulmonary fibrosis. |
| PubMedID- 20522855 | The use of abatacept in debilitating cavitating lung disease associated with rheumatoid arthritis, bronchocentric granulomatosis and aspergillosis. |
| PubMedID- 20884744 | lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. |
| PubMedID- 24681841 | Comment on: a case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis: reply. |
| PubMedID- 20480164 | A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab. |
| PubMedID- 22239947 | Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis. |
| PubMedID- 25665185 | Sonographic assessment of interstitial lung disease in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus. |
| PubMedID- 26090479 | Anti-cyclic citrullinated peptide antibodies and severity of interstitial lung disease in women with rheumatoid arthritis. |
| PubMedID- 20851924 | However, mortality rates from rheumatoid arthritis-associated interstitial lung disease increased 28.3% in women (to 3.1 per million persons in 2004) and declined 12.5% in men (to 1.5 per million persons in 2004). |
| PubMedID- 23819345 | [diagnosis and problems in therapy of interstitial lung disease associated with rheumatoid arthritis]. |
| PubMedID- 25026811 | [subclinical interstitial lung disease associated with rheumatoid arthritis]. |
| PubMedID- 22185348 | A novel model of rheumatoid arthritis-associated interstitial lung disease in skg mice. |
| PubMedID- 21325762 | Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of pneumocystis pneumonia in japan revealed by a multicenter study. |
| PubMedID- 22806097 | We also present a third clinical entity, that of lung disease associated with rheumatoid arthritis (rheumatoid lung), representing a condition that can manifest as either phenotype, and offering a potential opportunity to explore the mechanisms underlying the pathogenesis of the two distinct fibrotic phenotypes. |
| PubMedID- 22265461 | Rheumatoid nodules are a rare manifestation of lung disease associated with rheumatoid arthritis (ra). |
| PubMedID- 23588941 | Prognostic factors and radiographic outcomes of nontuberculous mycobacterial lung disease in rheumatoid arthritis. |
| PubMedID- 24681838 | Comment on: a case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis. |
| PubMedID- 25417684 | Abatacept therapy in rheumatoid arthritis with interstitial lung disease. |
| PubMedID- 25836639 | lung disease in rheumatoid arthritis. |
| PubMedID- 24626274 | Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis. |
| PubMedID- 25744479 | Backgrounds: interstitial lung disease (ild) is associated with rheumatoid arthritis (ra) itself and is also induced by biological and non-biological disease-modifying antirheumatic drugs. |
| PubMedID- 24909129 | Methotrexate and lung disease in rheumatoid arthritis: comment on the article by conway et al. |
| PubMedID- 22084614 | We report a case of a 52-year-old woman with a 1-year history of rheumatoid arthritis-associated interstitial lung disease referred to hospital because of aggravated pulmonary symptoms in spite of intensive treatment including prednisone, azathioprine and triptergium glycoside. |
| PubMedID- 26075419 | A guide to improving detection of interstitial lung disease in patients with rheumatoid arthritis. |
Page: 1